Medicine
Diazepam 5 mg/mL oral solution
Diazepam 5 mg/mL oral solution is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Diazepam Oral Solution (Concentrate), 5 mg…
Key facts
- Active ingredient (INN)
- Diazepam
- Brand
- Sold under the generic name
- Strength
- 5 mg/mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 30 mL
- Manufacturer
- Chartwell RX
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Diazepam Oral Solution (Concentrate), 5 mg per mL (Clear, yellow solution) is supplied as follows: NDC 62135-768-43: Bottle of 30 mL Store at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N05BA01 Diazepam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 April 2014
- Identifiers
- RxCUI 309843, 309844DailyMed set ID cdb839fb-27e5-4a11-aed6-da0a7ab6e996NDC 62135-768Application ANDA204433
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 mL in 1 bottle | 62135-768-43 | Chartwell RX | 17 August 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 November 1963 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Diazepam
Clinical summary
Diazepam is a benzodiazepine indicated for the treatment of anxiety disorders Short-term treatment of anxiety symptoms Treatment of tremor, acute agitation, among other approved uses. MedsAcross supplies Diazepam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DiazepamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Valium prescribing information (Waylis Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Diazepam 5 mg/mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.